These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26917231)

  • 1. CT Features of Epidermal Growth Factor Receptor-Mutated Adenocarcinoma of the Lung: Comparison with Nonmutated Adenocarcinoma.
    Hasegawa M; Sakai F; Ishikawa R; Kimura F; Ishida H; Kobayashi K
    J Thorac Oncol; 2016 Jun; 11(6):819-26. PubMed ID: 26917231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma.
    Park J; Kobayashi Y; Urayama KY; Yamaura H; Yatabe Y; Hida T
    PLoS One; 2016; 11(8):e0161081. PubMed ID: 27518729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation.
    Choi CM; Kim MY; Hwang HJ; Lee JB; Kim WS
    Radiology; 2015 Apr; 275(1):272-9. PubMed ID: 25575117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT characteristics of non-small cell lung cancer with epidermal growth factor receptor mutation: a systematic review and meta-analysis.
    Cheng Z; Shan F; Yang Y; Shi Y; Zhang Z
    BMC Med Imaging; 2017 Jan; 17(1):5. PubMed ID: 28068946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma.
    Liu Y; Kim J; Qu F; Liu S; Wang H; Balagurunathan Y; Ye Z; Gillies RJ
    Radiology; 2016 Jul; 280(1):271-80. PubMed ID: 26937803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes.
    Lee HJ; Kim YT; Kang CH; Zhao B; Tan Y; Schwartz LH; Persigehl T; Jeon YK; Chung DH
    Radiology; 2013 Jul; 268(1):254-64. PubMed ID: 23468578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor mutation status in stage I lung adenocarcinoma with different image patterns.
    Hsu KH; Chen KC; Yang TY; Yeh YC; Chou TY; Chen HY; Tsai CR; Chen CY; Hsu CP; Hsia JY; Chuang CY; Tsai YH; Chen KY; Huang MS; Su WC; Chen YM; Hsiung CA; Chang GC; Chen CJ; Yang PC
    J Thorac Oncol; 2011 Jun; 6(6):1066-72. PubMed ID: 21512404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma.
    Zou J; Lv T; Zhu S; Lu Z; Shen Q; Xia L; Wu J; Song Y; Liu H
    Thorac Cancer; 2017 May; 8(3):260-270. PubMed ID: 28383802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the Lung.
    Ozkan E; West A; Dedelow JA; Chu BF; Zhao W; Yildiz VO; Otterson GA; Shilo K; Ghosh S; King M; White RD; Erdal BS
    AJR Am J Roentgenol; 2015 Nov; 205(5):1016-25. PubMed ID: 26496549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases.
    Han HS; Eom DW; Kim JH; Kim KH; Shin HM; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Koo JH; Lee HC; Lee OJ
    Clin Lung Cancer; 2011 Nov; 12(6):380-6. PubMed ID: 21729655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes.
    Hong SJ; Kim TJ; Choi YW; Park JS; Chung JH; Lee KW
    Eur Radiol; 2016 Oct; 26(10):3660-8. PubMed ID: 26787602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between clinical data and computed tomography features in patients with epidermal growth factor receptor mutations in lung adenocarcinoma.
    Cao Y; Xu H; Liao M; Qu Y; Xu L; Zhu D; Wang B; Tian S
    Int J Clin Oncol; 2018 Apr; 23(2):249-257. PubMed ID: 28988295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity.
    Yoshida Y; Kokubu A; Suzuki K; Kuribayashi H; Tsuta K; Matsuno Y; Kusumoto M; Kanai Y; Asamura H; Hirohashi S; Shibata T
    Jpn J Clin Oncol; 2007 Dec; 37(12):907-12. PubMed ID: 18089646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation.
    Zhao J; Dinkel J; Warth A; Penzel R; Reinmuth N; Schnabel P; Muley T; Meister M; Zabeck H; Steins M; Yang JY; Zhou Q; Schlemmer HP; Herth FJF; Kauczor HU; Heussel CP
    PLoS One; 2017; 12(9):e0182741. PubMed ID: 28949965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT and clinical characteristics that predict risk of EGFR mutation in non-small cell lung cancer: a systematic review and meta-analysis.
    Zhang H; Cai W; Wang Y; Liao M; Tian S
    Int J Clin Oncol; 2019 Jun; 24(6):649-659. PubMed ID: 30835006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil.
    Mochinaga K; Tsuchiya T; Nagasaki T; Arai J; Tominaga T; Yamasaki N; Matsumoto K; Miyazaki T; Nanashima A; Hayashi T; Tsukamoto K; Nagayasu T
    Clin Lung Cancer; 2014 Mar; 15(2):136-144.e4. PubMed ID: 24405586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are there imaging characteristics associated with epidermal growth factor receptor and KRAS mutations in patients with adenocarcinoma of the lung with bronchioloalveolar features?
    Glynn C; Zakowski MF; Ginsberg MS
    J Thorac Oncol; 2010 Mar; 5(3):344-8. PubMed ID: 20087229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR mutations are associated with higher incidence of distant metastases and smaller tumor size in patients with non-small-cell lung cancer based on PET/CT scan.
    Guan J; Chen M; Xiao N; Li L; Zhang Y; Li Q; Yang M; Liu L; Chen L
    Med Oncol; 2016 Jan; 33(1):1. PubMed ID: 26589606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed Tomography Features of Lung Adenocarcinomas With Programmed Death Ligand 1 Expression.
    Toyokawa G; Takada K; Okamoto T; Shimokawa M; Kozuma Y; Matsubara T; Haratake N; Takamori S; Akamine T; Katsura M; Shoji F; Oda Y; Maehara Y
    Clin Lung Cancer; 2017 Nov; 18(6):e375-e383. PubMed ID: 28385373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
    Kim YT; Seong YW; Jung YJ; Jeon YK; Park IK; Kang CH; Kim JH
    J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.